An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 988-1000

  Bennett, C Frank ^a   Kornbrust, Doug ^a   Henry, Scott ^a   Stecker, Kim ^a   Howard, Randy ^a   Cooper, Scott ^a   Dutson, Sheryl ^b   Hall, William ^c   Jacoby, Henry I ^d  

^a ISIS PHARMACEUTICALS   (United States)

^b Utah Biomedical Test Laboratory   (United States)

^c CHARLES RIVER LABORATORIES   (United States)

^d Discovery Research Consultants LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CD11B ANTIGEN; CYCLOSPORIN A; DEXTRAN SULFATE; INTERCELLULAR ADHESION MOLECULE 1; ISIS 3082; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PREDNISOLONE; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; SPLEEN WEIGHT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BASE SEQUENCE; BLOOD CELL COUNT; BODY WEIGHT; COLITIS; COLON; DEXTRAN SULFATE; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; INTESTINAL MUCOSA; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MACROPHAGE-1 ANTIGEN; MALE; MICE; OLIGONUCLEOTIDES, ANTISENSE; ORGAN SIZE; SEX CHARACTERISTICS; THIONUCLEOTIDES;

EID: 0030980684     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. ADAMS, D. H., HUBSCHER, S. G., SHAW, J., ROTHLEIN, R. AND NEUBERGER, J. M.: Intercellular adhesion molecule 1 on liver allografts during rejection. The Lancet 2: 1122-1125, 1989.
2. AGRAWAL, S., TEMSAMANI, J. AND TANG, J. Y.: Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc. Natl. Acad. Sci. U.S.A. 88: 7595-7599, 1991.
3. ALBELDA, S. M., SMITH, C. W. AND WARD, P. A.: Adhesion molecules and inflammatory injury. FASEB J. 8: 504-512, 1994.
4. ANDRADE, M., SCOZZARI, A., COLE, D. L. AND RAVIKUMAR, V. T.: Efficient synthesis of antisense oligodeoxyribonucleotide phosphorothioates. Bioorg. Med. Chem. Lett. 4: 2017-2022, 1994.
5. BENNETT, C. F., CHIANG, M.-Y., CHAN, H., SHOEMAKER, J. E. E. AND MIRABELLI, C. K.: Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41: 1023-1033, 1992.
6. BENNETT, C. F., CONDON, T., GRIMM, S., CHAN, H. AND CHIANG, M.-Y.: Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152: 3530-3540, 1994.
7. BENNETT, C. F. AND CROOKE, S. T.: Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides. Adv. Pharmacol. 28: 1-43, 1994.
8. BENNETT, C. F., ZUCKERMAN, J. E., KORNBRUST, D., SASMOR, H., LEEDS, J. M. AND CROOKE, S. T.: Pharmacokinetics in mice of a [3H]-labeled phosphorothioate oligonucleotide formulated in the presense and absence of a cationic lipid. J. Control. Rdel. 41: 121-130, 1996. (in press)
9. BEVILACQUA, M. P.: Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 11: 767-804, 1993.
10. BUTCHER, E. C.: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67: 1033-1036, 1991.
11. CHIANG, M.-Y., CHAN, H., ZOUNES, M. A., FREIER, S. M., LIMA, W. F. AND BENNETT, C. F.: Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms. J. Biol. Chem. 266: 18162-18171, 1991.
12. COOPER, H. S., MURTHY, S. N. S., SHAH, R. P. AND SEDERGRAN, D. J.: Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69: 238-249, 1993.
13. COSIMI, A. B., CONTI, D., DELMONICO, F. L., PREFFER, F. I., WEE, S.-L., ROTHLEIN, R., FAANES, R. AND COLVIN, R. B.: In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. 144: 4604-4612, 1990.
14. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J. Pharmacol. Exp. Ther. 267: 1181-1190, 1993.
15. CROOKE, S. T.: Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol. 32: 329-376, 1992.
16. CROOKS S. T.: Therapeutic Applications of Oligonucleotides, pp. 138 R. G. Landes Company, Austin, 1995.
17. CROOKE, S. T., GRAHAM, M. J., ZUCKERMAN, J. E., BROOKS, D., CONKLIN, B. S., CUMMINS, L. L., GREIG, M. J., GUINOSSO, C. J., KORNBRUST, D., MANOHARAN, M., SASMOR, H. M., SCHLEICH, T., TIVEL, K. L. AND GRIFFEY, R. H.: Pharmacokinetic properties of several novel oligonucleotide analogs in mice. J. Pharmacol. Exp. Ther. 277: 923-937, 1996.
18. DAMLE, N.K., KLUSSMAN, K., LINSLEY, P. S. AND ARUFFO, A.: Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T Lymphocytes. J. Immunol. 148: 1985-1992, 1992.
19. DAMLE, N. K., KLUSSMAN, K., LEYTZE, G., MYRDAL, S., ARUFFO, A., LEDBETTER, J. A. AND LINSLEY, P. S.: Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol. 152: 2686-2697, 1994.
20. DEAN, N. M. AND MCKAY, R.: Inhibition of protein kinase C-alpha expression in mice after systemic administration of phoaphorothioate antisense oligodeoxynucleotides. Proc. Natl. Acad. Sci. U.S.A. 91: 11762-11766, 1994.
21. DIAMOND, M. S., STAUNTON, D. E., DEFOUGEROLLES, A. R., STACKER, S. A., GARCIA-AGUILAR, J., HIBBS, M. L. AND SPRINGER, T. A.: ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111: 3129-3139, 1990.
22. DUSTIN, M. L., ROTHLEIN, R., BHAN, A. K., DINARELLO, C. A. AND SPRINGER, T. A.: Induction by IL 1 and interferon-s: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254, 1986.
23. GRIFFITHS, C. E. M., VOORHEES, J. J. AND NICKOLOFF, B. J.: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma Interferon and tumor necrosis factor. J. Am. Acad. Dermatol. 20: 617-629, 1989.
24. GUNDEL, R. H., WEGNER, C. D., TORCELLINI, C. A., CLARKE, C. C., HAYNES, N., ROTHLEIN, R., SMITH, C. W. AND LETTS, L. G.: Endothelial leukocyte adhesion molecule-1 mediates antigen-induced acute airway inflammation and latephase airway obstruction in monkeys. J. Clin. Invest. 88: 1407-1411, 1991.
25. HALE, L. P., MARTIN, M. E., MCCOLLUM, D. E., NUNLEY, J. A., SPRINGER, T. A., SINGER, K. H. AND HAYNES, B. F.: Immunohistologic analysis of the distribtuion of cell adhesion molecules within the inflammatory synovial microenvironment. Arthritis and Rheumatism 32: 22-30, 1989.
26. HARLAN, J. M., WINN, R. K., VEDDER, N. B., DOERSCHUK, C. M. AND RICE, C. L.: In vivo models of leukocyte adherence to endothelium. In Adhesion. Its Role in Inflammatory Disease, ed. by J. M. Harlan and D. Y. Liu, pp. 117-150, W. H. Freeman, New York, 1992.
27. HAUG, C. E., COLVIN, R. B., DELNONICO, F. L., AUCHINCLOSS, H., TOLKOFF-RUBIN, N., PREFFER, F. I., ROTHLEIN, R., NORRIS, S., SCHARSCHMIDT, L. AND COBIMI, A. B.: A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55: 766-773, 1993.
28. JAMES, S. P., FIOCCHI, C., GRAEFF, A. S. AND STROBER, W.: Phenotypic analysis of lamina propria lymphocytes. Gastroenterology 91: 1483-1489, 1986.
29. KAVANAUGH, A. F., DAVIS, L. S., NICHOLS, L. A., NORRIS, S. H., ROTHLEIN, R., SCHARSCHMIDT, L. A. AND LIPSKY, P. E.: Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37: 992-999, 1994.
30. KOBAYASHI, K., ASAKURA, H., HAMADA, Y., HIBI, T., WATANABE, M., YOSHIDA, T., WATANABE, N., MIURA, S., AISO, S. AND TSUCCHIYA, M.: T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulceralive colitis; a morphometric and immunohistochemical study. J. Clin. Lab. Immunol. 25: 63-68, 1988.
31. KOIZUMI, M., KING, N., LOBB, R., BENJAMIN, C. ANN PODOLSKY, D. K.: Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103: 840-847, 1992.
32. KONTTINEN, Y. T., BERGROTH, V., NORDSTROM, D., SEGERBERG-KONTTINEN, M., SEPPALA, K. AND SALASPURO, M.: Lymphocyte activation in vivo in the intestinal mucosa of patients with Crohn's disease. J. Clin. Lab. Immunol. 22: 59-63, 1987.
33. KOOPMAN, G., KEEHNEN, R. M. J., LINDHOUT, E., NEWMAN, W., SHIMIZU, Y., VAN SEVENTER, G. A., DE GROOT, C. AND PALS, S. T.: Adhesion through the LFA-1 (CD11a/CD18)-ICAM-l (CD54) and the VLA-4 (CCD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells. J. Immunol. 152: 3760-3767, 1994.
34. KRIEG, A. M., YI, A.-K., MATSON, S., WALDSCHMIDT, T. J., BISHOP, G. A., TEASDALE, R., KORETZKY, G. A. AND KLINMAN, D. M.: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (Lond.) 374: 546-549, 1995.
35. KUHLMAN, P., MOY, V. T., LOLLO, B. A. AND BRIAN, A. A.: The accessory function of murine intercellular adhesion molecule-1 in T lymphocyte activation. J. Immunol. 146: 1773-1782, 1991.
36. KUMASAKA, T., QUINLAN, W. M., DOYLE, N. A., CONDON, T. P., SLIGH, J., TAKEI, F., BEAUDET, A. L., BENNETT, C. F. AND DOERSCHUK, C. M.: The role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest. 97: 2362-2369, 1996.
37. LICHENSTEIN, G. R.: Medical therapies for inflammatory bowel disease. Curr. Opin. Gastro. 9: 588-599, 1993.
38. MA, X.-L., LEFER, D. J., LEFER, A. M. AND ROTHLEIN, R.: Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
39. MARLIN, S. D. AND SPRINGER, T. A.: Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 51: 813-819, 1987.
40. MATSUMOTO, T., KITANO, A., NAKAMURA, S., OSHITANI, N., OBATA, A., HIKI, M., HASHIMURA, H., OKAWA, K., KOBAYASHI, K. AND NAGURA, H.: Possible role of vascular endothelial cells in immune responses in colonic mucosa examined immunocytochemically in subjects with and without ulcerative colitis. Clin. Exp. Immunol. 78: 424-430, 1989.
41. MCDONALD, G. B. AND JEWELL, D. P.: Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of the colon. J. Clin. Pathol. 40: 312-317, 1987.
42. MULLIGAN, M. S., VARANI, J., DAME, M. K., LANE, C. L., SMITH, C. W., ANDERSON, D. C. AND WARD, P. A.: Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rata. J. Clin. Invest. 88: 1396-1406, 1991.
43. MULLIN, G. E., LAZENBY, A. J., HARRIS, M. L., BAYLESS, T. M. AND JAMES, S. P.: Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102: 1620-1627, 1992.
44. MURTHY, S., COOPER, H., COPPOLA, D., BARISH, S., MCKIBBIN, R., CERLETTI, N. AND DIMUZIO, J.: Transforming growth factor beta2 (TGFB), but not epidermal growth factor (EGF), yields protection against dextran sulfate (DSS)-mediated colitis in mice. Gastroenterology A669, 1992.
45. MURTHY, S. N. S., COOPER, H. S., SHIM, H., SHAH, R. S., IBRAHIM, S. A. AND SEDERGRAN, D. J.: Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38: 1722-1734, 1993.
46. NAKAMURA, S., OHTANI, H., WATANABE, Y., FUKUSHIMA, K., MATSUMOTO, T., KITANO, A., KOBAYASHI, K. AND NAGURA, H.: In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab. Invest. 69: 77-85, 1993.
47. OKAYASU, I., HATAKEYAMA, S., YAMADA, M., OHKUSA, T., INAGAKI, Y. AND NAKAYA, R.: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702, 1990.
48. PISETSKY, D. S. AND REICH, C. F.: Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Sci. 54: 101-107, 1994.
49. PODOLSKY, D. K.: Inflammatory bowel disease. N. Eng. J. Med. 325: 1008-1016, 1993.
50. POSTON, R. N., HASKARD, D. O., COUCHER, J. R., GALL, N. P. AND JOHNSON-TIDEY, R. R.: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140: 665-673, 1992.
51. POUDIER, J. AND OWENS, T.: CD54/Intercellular adhesion molecule 1 and major histocompatibility complex II signalling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J. Exp. Mod. 179: 1417-1427, 1994.
52. ROTHLEIN, R., DUSTIN, M. L., MARLIN, S. D. AND SPRINGER, T. A.: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 137: 1270-1274, 1986.
53. SANCHEZ-MADRID, F., SIMON, P., THOMPSON, S. AND SPRINGER, T. A.: Mapping of antigenic and functional epitopes on the alpha and beta subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and MAC-1. J. Exp. Med. 158: 586-602, 1983.
54. SCHUERMANN, G. M., ABER-BISHOP, A. E., FACER, P., LEE, J. C., RAMPTON, D. S., DORÉ, C. J. AND POLAK, J. M.: Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin. Exp. Immunol. 94: 341-347, 1993.
55. SELBY, W. S., JANOSSY, G., MASON, D. Y. AND JEWELL, D. P.: Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin. Exp. Immunol. 53: 614-618, 1983.
56. SHANAHAN, F.: Pathogenesis of ulcerative colitis. Lancet 342: 407-411, 1993.
57. SPRINGER, T. A.: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76: 301-314, 1994.
58. STEIN, C. A. AND CHENG, Y.-C.: Antisense oligonucleotides as therapeutic agents: Is the bullet really magical? Science (Wash. DC) 261: 1004-1012, 1993.
59. STEPKOWSKI, S. M., TU, Y., CONDON, T. P. AND BENNETT, C. F.: Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. J. Immunol. 153: 5336-5346, 1994.
60. TAKEI, F.: Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J. Immunol. 134: 1403-1407, 1985.
61. VAN SEVENTER, G. A., SHIMIZU, Y., HORGAN, K. J. AND SHAW, S.: The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144: 4579-4586, 1990.
62. WEGNER, C. D., GUNDEL, R. H., REILLY, P., HAYNES, N., LETTS, L. G. AND ROTHLEIN, R.: Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science (Wash. DC) 247: 456-459, 1990.
63. WINN, R. K., LIGGITT, D., VEDDER, N. B., PAULSON, J. C. AND HARLAN, J. M.: Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J. Clin. Invest. 92: 2042-2047, 1993.
64. YACYSHYN, B. R., LAZAROVITS, A., TSAI, V. AND MATEJKO, K.: Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns. Gastroenterology 107: 1364-1371, 1994.
65. ZHANG, R., DIASIO, R. B., LU, Z., LIU, T., JIANG, Z., GALBRAITH, W. M. AND AGRAWAL, S.: Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1. Biochem. Pharmacol. 49: 929-939, 1995.
66. ZHAO, Q., TEMSAMANI, J., IADAROLA, P. L., JIANG, Z. AND AGRAWAL, S.: Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem. Pharm. 51: 173-182, 1995.
67. ZHOU, L., MOROCHO, A. M., CHEN, B. AND COHEN, J. S.: Synthesis of phosphorothioate-methylphosphonate oligonucleotide co-polymers. Nucleic Acids Res. 22: 453-456, 1994.